Dr. Nywana Sizemore

Dr. Nywana Sizemore

Scientific Review Officer


Division of Basic and Integrative Biological Sciences DBIB
Review Branch:
Basic and Translational Cancer BTC
Study Section:
Fellowships: Oncological Sciences F09B

Dr. Nywana Sizemore received her Ph.D. from Case Western Reserve University for her work on the interactions of human papillomavirus and epidermal growth factor signaling in human ectocervical epithelial cells. Her postdoctoral work focused on the role of growth factor signaling in Ras-mediated transformation at Vanderbilt University. The next phase of her work centered on AKT and PTEN signaling in the regulation of the nuclear factor-kappaB (NFkB) transcription factor at the Cleveland Clinic. Before joining CSR, Dr. Sizemore was an assistant professor in the Department of Cancer Biology at the Cleveland Clinic, where she expanded her research into the investigation of novel targets of the AKT/inhibitor of kappaB kinase (IKK) pathway in colorectal cancer with grant support from NIH.


Last updated: 12/01/2023 14:24